Qube Research & Technologies Ltd acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPW) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 16,504 shares of the real estate investment trust’s stock, valued at approximately $288,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. BlackRock Inc. grew its holdings in Medical Properties Trust by 3.4% in the 1st quarter. BlackRock Inc. now owns 44,368,188 shares of the real estate investment trust’s stock valued at $821,255,000 after buying an additional 1,459,646 shares in the last quarter. LSV Asset Management grew its holdings in Medical Properties Trust by 1.9% in the 1st quarter. LSV Asset Management now owns 10,444,707 shares of the real estate investment trust’s stock valued at $193,331,000 after buying an additional 195,400 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Medical Properties Trust by 1.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 5,704,888 shares of the real estate investment trust’s stock valued at $91,734,000 after buying an additional 102,274 shares in the last quarter. Northern Trust Corp grew its holdings in Medical Properties Trust by 5.5% in the 1st quarter. Northern Trust Corp now owns 5,192,317 shares of the real estate investment trust’s stock valued at $96,109,000 after buying an additional 270,206 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Medical Properties Trust by 22.9% in the 4th quarter. Geode Capital Management LLC now owns 4,659,679 shares of the real estate investment trust’s stock valued at $74,927,000 after buying an additional 867,172 shares in the last quarter. 70.05% of the stock is currently owned by hedge funds and other institutional investors.
Shares of MPW traded up $0.08 during trading hours on Wednesday, hitting $18.33. 25,985 shares of the company were exchanged, compared to its average volume of 4,373,321. The company has a market cap of $8.14 billion, a price-to-earnings ratio of 13.34, a P/E/G ratio of 3.43 and a beta of 0.60. Medical Properties Trust, Inc. has a fifty-two week low of $13.98 and a fifty-two week high of $18.92. The company has a quick ratio of 8.00, a current ratio of 8.00 and a debt-to-equity ratio of 0.99. The firm’s fifty day moving average is $17.98 and its 200 day moving average is $18.09.
The business also recently announced a quarterly dividend, which will be paid on Thursday, October 10th. Stockholders of record on Thursday, September 12th will be issued a dividend of $0.26 per share. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.25. This represents a $1.04 annualized dividend and a dividend yield of 5.67%. The ex-dividend date of this dividend is Wednesday, September 11th. Medical Properties Trust’s dividend payout ratio is 72.99%.
In related news, Director G Steven Dawson bought 7,476 shares of Medical Properties Trust stock in a transaction dated Thursday, August 8th. The shares were bought at an average cost of $18.07 per share, with a total value of $135,091.32. Following the acquisition, the director now owns 76,302 shares in the company, valued at approximately $1,378,777.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Emmett E. Mclean sold 100,000 shares of the stock in a transaction on Monday, August 19th. The stock was sold at an average price of $18.37, for a total value of $1,837,000.00. Following the sale, the insider now directly owns 1,066,337 shares in the company, valued at $19,588,610.69. The disclosure for this sale can be found here. Over the last three months, insiders have sold 176,830 shares of company stock worth $3,207,050. 1.18% of the stock is currently owned by insiders.
A number of research analysts have commented on the company. Stifel Nicolaus set a $21.00 price objective on Medical Properties Trust and gave the company a “buy” rating in a report on Monday, August 12th. Deutsche Bank raised Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Monday, July 29th. Zacks Investment Research lowered Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Wednesday, July 17th. ValuEngine lowered Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, SunTrust Banks raised Medical Properties Trust from a “hold” rating to a “buy” rating and upped their price objective for the company from $19.00 to $20.00 in a report on Tuesday, July 2nd. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. Medical Properties Trust has a consensus rating of “Buy” and a consensus target price of $18.94.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Story: Death Cross
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW).
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.